Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | HGNC ID | DiseaseId | DiseaseName | Frequency | Onset | HGMD variants | ClinVar variants |
---|
HPO disease - gene - phenotype typical associations: |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | ACE CL E G H | 1636 | 2707 | OMIM:267430 | Renal tubular dysgenesis | | | | 113 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | AGT CL E G H | 183 | 333 | OMIM:267430 | Renal tubular dysgenesis | | | | 48 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | AGTR1 CL E G H | 185 | 336 | OMIM:267430 | Renal tubular dysgenesis | | | | 33 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | APRT CL E G H | 353 | 626 | ORPHA:976 | Adenine phosphoribosyltransferase deficiency | | | | 19 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | APRT CL E G H | 353 | 626 | OMIM:614723 | Adenine phosphoribosyltransferase deficiency | | | | 19 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | AQP2 CL E G H | 359 | 634 | OMIM:125800 | Diabetes insipidus, nephrogenic, 2 | | | | 75 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | ATP1A1 CL E G H | 476 | 799 | OMIM:618314 | Hypomagnesemia, seizures, and mental retardation 2 | | | | 4 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | AVPR2 CL E G H | 554 | 897 | OMIM:304800 | Diabetes insipidus, nephrogenic, X-linked | | | | 67 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | BSND CL E G H | 7809 | 16512 | OMIM:602522 | Bartter syndrome, type 4A, neonatal, with sensorineural deafness | | | | 53 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | C3 CL E G H | 718 | 1318 | OMIM:612925 | Hemolytic uremic syndrome, atypical, susceptibility to, 5 | | | | 92 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | CASR CL E G H | 846 | 1514 | OMIM:239200 | Hyperparathyroidism, neonatal severe | | | | 272 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | CAV1 CL E G H | 857 | 1527 | ORPHA:220393 | Diffuse cutaneous systemic sclerosis | | | | 11 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | CAV1 CL E G H | 857 | 1527 | OMIM:606721 | Lipodystrophy, familial partial, type 7 | | | | 11 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | CCN2 CL E G H | 1490 | 2500 | ORPHA:220393 | Diffuse cutaneous systemic sclerosis | | | | | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | CCR6 CL E G H | 1235 | 1607 | ORPHA:220393 | Diffuse cutaneous systemic sclerosis | | | | | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | CD46 CL E G H | 4179 | 6953 | OMIM:612922 | Hemolytic uremic syndrome, atypical, susceptibility to, 2 | | | | 39 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | CFB CL E G H | 629 | 1037 | OMIM:612924 | Hemolytic uremic syndrome, atypical, susceptibility to, 4 | | | | 30 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | CFH CL E G H | 3075 | 4883 | OMIM:235400 | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | | | | 86 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | CFHR1 CL E G H | 3078 | 4888 | OMIM:235400 | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | | | | | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | CFHR3 CL E G H | 10878 | 16980 | OMIM:235400 | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | | | | | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | CFI CL E G H | 3426 | 5394 | OMIM:612923 | Hemolytic uremic syndrome, atypical, susceptibility to, 3 | | | | 57 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | CLCNKA CL E G H | 1187 | 2026 | OMIM:613090 | Bartter syndrome, type 4B, neonatal, with sensorineural deafness | | | | 9 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | CLCNKB CL E G H | 1188 | 2027 | OMIM:607364 | Bartter syndrome, type 3 | | | | 27 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | CLCNKB CL E G H | 1188 | 2027 | OMIM:613090 | Bartter syndrome, type 4B, neonatal, with sensorineural deafness | | | | 27 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | CLDN10 CL E G H | 9071 | 2033 | OMIM:617671 | Helix syndrome | | | | 3 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | CLDN16 CL E G H | 10686 | 2037 | OMIM:248250 | Hypomagnesemia 3, renal | | | | 58 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | COX1 CL E G H | 4512 | 7419 | ORPHA:99845 | Genetic recurrent myoglobinuria | | | | | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | COX3 CL E G H | 4514 | 7422 | ORPHA:99845 | Genetic recurrent myoglobinuria | | | | | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | CTNS CL E G H | 1497 | 2518 | OMIM:219800 | Cystinosis, nephropathic | | | | 178 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | CYP24A1 CL E G H | 1591 | 2602 | OMIM:143880 | Hypercalcemia, infantile, 1 | | | | 73 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | DMP1 CL E G H | 1758 | 2932 | ORPHA:289176 | Autosomal recessive hypophosphatemic rickets | HP:0040281 - Very frequent | | | 48 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | DZIP1L CL E G H | 199221 | 26551 | ORPHA:731 | Autosomal recessive polycystic kidney disease | | | | 4 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | ENPP1 CL E G H | 5167 | 3356 | ORPHA:289176 | Autosomal recessive hypophosphatemic rickets | HP:0040281 - Very frequent | | | 151 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | FAM20A CL E G H | 54757 | 23015 | OMIM:204690 | Enamel-Renal syndrome | | | | 16 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | GALNT3 CL E G H | 2591 | 4125 | OMIM:211900 | Tumoral calcinosis, hyperphosphatemic, familial, 1 | | | | 46 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | HLA-DRB1 CL E G H | 3123 | 4948 | ORPHA:220393 | Diffuse cutaneous systemic sclerosis | | | | 2 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | HNF1A CL E G H | 6927 | 11621 | OMIM:222100 | Diabetes mellitus, insulin-dependent-1 | | | | 161 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | IL6 CL E G H | 3569 | 6018 | OMIM:222100 | Diabetes mellitus, insulin-dependent-1 | | | | 2 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | IRF5 CL E G H | 3663 | 6120 | ORPHA:220393 | Diffuse cutaneous systemic sclerosis | | | | 4 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | ITPR3 CL E G H | 3710 | 6182 | OMIM:222100 | Diabetes mellitus, insulin-dependent-1 | | | | | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | KCNJ1 CL E G H | 3758 | 6255 | OMIM:241200 | Bartter syndrome, antenatal, type 2 | | | | 51 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | KCNJ10 CL E G H | 3766 | 6256 | OMIM:612780 | Seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance | | | | 121 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | KCNJ5 CL E G H | 3762 | 6266 | OMIM:613677 | Hyperaldosteronism, familial, type III | | | | 128 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | LPIN1 CL E G H | 23175 | 13345 | ORPHA:99845 | Genetic recurrent myoglobinuria | | | | 95 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | LZTFL1 CL E G H | 54585 | 6741 | OMIM:615994 | BARDET-BIEDL SYNDROME 17; BBS17 | | | | 4 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | MAGED2 CL E G H | 10916 | 16353 | OMIM:300971 | Bartter syndrome, type 5, antenatal, transient | | | | 6 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | MUC1 CL E G H | 4582 | 7508 | OMIM:174000 | Tubulointerstitial kidney disease, autosomal dominant, 2 | | | | 1 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | MYH11 CL E G H | 4629 | 7569 | OMIM:619351 | MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME 2; MMIHS2 | | | | 418 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | NPHP1 CL E G H | 4867 | 7905 | OMIM:256100 | Nephronophthisis 1 | | | | 85 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | NPHP1 CL E G H | 4867 | 7905 | OMIM:266900 | Senior-Loken syndrome 1 | | | | 85 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | NPHP3 CL E G H | 27031 | 7907 | OMIM:604387 | Nephronophthisis 3 | | | | 157 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | NPHP4 CL E G H | 261734 | 19104 | OMIM:606966 | Nephronophthisis 4 | | | | 220 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | NPHP4 CL E G H | 261734 | 19104 | OMIM:606996 | Senior-Loken syndrome 4 | | | | 220 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | PAX2 CL E G H | 5076 | 8616 | ORPHA:97362 | Renal hypoplasia, bilateral | | | | 39 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | PBX1 CL E G H | 5087 | 8632 | ORPHA:97362 | Renal hypoplasia, bilateral | | | | 3 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | PKHD1 CL E G H | 5314 | 9016 | ORPHA:731 | Autosomal recessive polycystic kidney disease | | | | 563 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | PLVAP CL E G H | 83483 | 13635 | OMIM:618183 | Diarrhea 10, protein-losing Enteropathy type | | | | | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | PTPN22 CL E G H | 26191 | 9652 | OMIM:222100 | Diabetes mellitus, insulin-dependent-1 | | | | 3 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | REN CL E G H | 5972 | 9958 | OMIM:267430 | Renal tubular dysgenesis | | | | 25 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | RYR1 CL E G H | 6261 | 10483 | ORPHA:466650 | Exercise-induced malignant hyperthermia | | | | 1200 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | SARS2 CL E G H | 54938 | 17697 | OMIM:613845 | Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis syndrome | | | | 60 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | SLC12A1 CL E G H | 6557 | 10910 | OMIM:601678 | Bartter syndrome, type 1, antenatal | | | | 75 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | SLC12A3 CL E G H | 6559 | 10912 | OMIM:263800 | Gitelman syndrome | | | | 145 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | SLC22A12 CL E G H | 116085 | 17989 | OMIM:220150 | Hypouricemia, renal, 1 | | | | 56 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | SLC25A20 CL E G H | 788 | 1421 | ORPHA:159 | Carnitine-acylcarnitine translocase deficiency | | | | 40 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | SLC34A1 CL E G H | 6569 | 11019 | OMIM:616963 | HYPERCALCEMIA, INFANTILE, 2; HCINF2 | | | | 47 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | SLC41A1 CL E G H | 254428 | 19429 | OMIM:619468 | NEPHRONOPHTHISIS-LIKE NEPHROPATHY 2; NPHPL2 | | | | | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | SLC5A2 CL E G H | 6524 | 11037 | OMIM:233100 | Renal glucosuria | | | | 41 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | SON CL E G H | 6651 | 11183 | OMIM:617140 | Zttk syndrome | | | | 12 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | THBD CL E G H | 7056 | 11784 | OMIM:612926 | Hemolytic uremic syndrome, atypical, susceptibility to, 6 | | | | 60 | | |
HP:0011036 | HP:0011036 | Abnormality of renal excretion | 0 | TMEM67 CL E G H | 91147 | 28396 | OMIM:613550 | NEPHRONOPHTHISIS 11; NPHP11 | | | | 166 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | ACE CL E G H | 1636 | 2707 | OMIM:267430 | Renal tubular dysgenesis | | | | 113 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | AGT CL E G H | 183 | 333 | OMIM:267430 | Renal tubular dysgenesis | | | | 48 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | AGTR1 CL E G H | 185 | 336 | OMIM:267430 | Renal tubular dysgenesis | | | | 33 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | APRT CL E G H | 353 | 626 | OMIM:614723 | Adenine phosphoribosyltransferase deficiency | | | | 19 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | APRT CL E G H | 353 | 626 | ORPHA:976 | Adenine phosphoribosyltransferase deficiency | | | | 19 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | AQP2 CL E G H | 359 | 634 | OMIM:125800 | Diabetes insipidus, nephrogenic, 2 | | | | 75 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | ATP1A1 CL E G H | 476 | 799 | OMIM:618314 | Hypomagnesemia, seizures, and mental retardation 2 | | | | 4 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | AVPR2 CL E G H | 554 | 897 | OMIM:304800 | Diabetes insipidus, nephrogenic, X-linked | | | | 67 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | BSND CL E G H | 7809 | 16512 | OMIM:602522 | Bartter syndrome, type 4A, neonatal, with sensorineural deafness | | | | 53 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | C3 CL E G H | 718 | 1318 | OMIM:612925 | Hemolytic uremic syndrome, atypical, susceptibility to, 5 | | | | 92 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | CASR CL E G H | 846 | 1514 | OMIM:239200 | Hyperparathyroidism, neonatal severe | | | | 272 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | CAV1 CL E G H | 857 | 1527 | ORPHA:220393 | Diffuse cutaneous systemic sclerosis | | | | 11 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | CAV1 CL E G H | 857 | 1527 | OMIM:606721 | Lipodystrophy, familial partial, type 7 | | | | 11 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | CCN2 CL E G H | 1490 | 2500 | ORPHA:220393 | Diffuse cutaneous systemic sclerosis | | | | | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | CCR6 CL E G H | 1235 | 1607 | ORPHA:220393 | Diffuse cutaneous systemic sclerosis | | | | | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | CD46 CL E G H | 4179 | 6953 | OMIM:612922 | Hemolytic uremic syndrome, atypical, susceptibility to, 2 | | | | 39 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | CFB CL E G H | 629 | 1037 | OMIM:612924 | Hemolytic uremic syndrome, atypical, susceptibility to, 4 | | | | 30 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | CFH CL E G H | 3075 | 4883 | OMIM:235400 | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | | | | 86 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | CFHR1 CL E G H | 3078 | 4888 | OMIM:235400 | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | | | | | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | CFHR3 CL E G H | 10878 | 16980 | OMIM:235400 | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | | | | | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | CFI CL E G H | 3426 | 5394 | OMIM:612923 | Hemolytic uremic syndrome, atypical, susceptibility to, 3 | | | | 57 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | CLCNKA CL E G H | 1187 | 2026 | OMIM:613090 | Bartter syndrome, type 4B, neonatal, with sensorineural deafness | | | | 9 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | CLCNKB CL E G H | 1188 | 2027 | OMIM:607364 | Bartter syndrome, type 3 | | | | 27 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | CLCNKB CL E G H | 1188 | 2027 | OMIM:613090 | Bartter syndrome, type 4B, neonatal, with sensorineural deafness | | | | 27 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | CLDN10 CL E G H | 9071 | 2033 | OMIM:617671 | Helix syndrome | | | | 3 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | CLDN16 CL E G H | 10686 | 2037 | OMIM:248250 | Hypomagnesemia 3, renal | | | | 58 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | COX1 CL E G H | 4512 | 7419 | ORPHA:99845 | Genetic recurrent myoglobinuria | | | | | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | COX3 CL E G H | 4514 | 7422 | ORPHA:99845 | Genetic recurrent myoglobinuria | | | | | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | CTNS CL E G H | 1497 | 2518 | OMIM:219800 | Cystinosis, nephropathic | | | | 178 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | CYP24A1 CL E G H | 1591 | 2602 | OMIM:143880 | Hypercalcemia, infantile, 1 | | | | 73 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | DZIP1L CL E G H | 199221 | 26551 | ORPHA:731 | Autosomal recessive polycystic kidney disease | | | | 4 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | FAM20A CL E G H | 54757 | 23015 | OMIM:204690 | Enamel-Renal syndrome | | | | 16 | | |
HP:0011036 | HP:0005572 | Decreased renal tubular phosphate excretion | 1 | GALNT3 CL E G H | 2591 | 4125 | OMIM:211900 | Tumoral calcinosis, hyperphosphatemic, familial, 1 | . | | | 46 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | HLA-DRB1 CL E G H | 3123 | 4948 | ORPHA:220393 | Diffuse cutaneous systemic sclerosis | | | | 2 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | HNF1A CL E G H | 6927 | 11621 | OMIM:222100 | Diabetes mellitus, insulin-dependent-1 | | | | 161 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | IL6 CL E G H | 3569 | 6018 | OMIM:222100 | Diabetes mellitus, insulin-dependent-1 | | | | 2 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | IRF5 CL E G H | 3663 | 6120 | ORPHA:220393 | Diffuse cutaneous systemic sclerosis | | | | 4 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | ITPR3 CL E G H | 3710 | 6182 | OMIM:222100 | Diabetes mellitus, insulin-dependent-1 | | | | | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | KCNJ1 CL E G H | 3758 | 6255 | OMIM:241200 | Bartter syndrome, antenatal, type 2 | | | | 51 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | KCNJ10 CL E G H | 3766 | 6256 | OMIM:612780 | Seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance | | | | 121 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | KCNJ5 CL E G H | 3762 | 6266 | OMIM:613677 | Hyperaldosteronism, familial, type III | | | | 128 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | LPIN1 CL E G H | 23175 | 13345 | ORPHA:99845 | Genetic recurrent myoglobinuria | | | | 95 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | LZTFL1 CL E G H | 54585 | 6741 | OMIM:615994 | BARDET-BIEDL SYNDROME 17; BBS17 | | | | 4 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | MAGED2 CL E G H | 10916 | 16353 | OMIM:300971 | Bartter syndrome, type 5, antenatal, transient | | | | 6 | | |
HP:0011036 | HP:0004732 | Impaired renal uric acid clearance | 1 | MUC1 CL E G H | 4582 | 7508 | OMIM:174000 | Tubulointerstitial kidney disease, autosomal dominant, 2 | . | | | 1 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | MYH11 CL E G H | 4629 | 7569 | OMIM:619351 | MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME 2; MMIHS2 | | | | 418 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | NPHP1 CL E G H | 4867 | 7905 | OMIM:256100 | Nephronophthisis 1 | | | | 85 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | NPHP1 CL E G H | 4867 | 7905 | OMIM:266900 | Senior-Loken syndrome 1 | | | | 85 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | NPHP3 CL E G H | 27031 | 7907 | OMIM:604387 | Nephronophthisis 3 | | | | 157 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | NPHP4 CL E G H | 261734 | 19104 | OMIM:606966 | Nephronophthisis 4 | | | | 220 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | NPHP4 CL E G H | 261734 | 19104 | OMIM:606996 | Senior-Loken syndrome 4 | | | | 220 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | PAX2 CL E G H | 5076 | 8616 | ORPHA:97362 | Renal hypoplasia, bilateral | | | | 39 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | PBX1 CL E G H | 5087 | 8632 | ORPHA:97362 | Renal hypoplasia, bilateral | | | | 3 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | PKHD1 CL E G H | 5314 | 9016 | ORPHA:731 | Autosomal recessive polycystic kidney disease | | | | 563 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | PLVAP CL E G H | 83483 | 13635 | OMIM:618183 | Diarrhea 10, protein-losing Enteropathy type | | | | | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | PTPN22 CL E G H | 26191 | 9652 | OMIM:222100 | Diabetes mellitus, insulin-dependent-1 | | | | 3 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | REN CL E G H | 5972 | 9958 | OMIM:267430 | Renal tubular dysgenesis | | | | 25 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | RYR1 CL E G H | 6261 | 10483 | ORPHA:466650 | Exercise-induced malignant hyperthermia | | | | 1200 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | SARS2 CL E G H | 54938 | 17697 | OMIM:613845 | Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis syndrome | | | | 60 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | SLC12A1 CL E G H | 6557 | 10910 | OMIM:601678 | Bartter syndrome, type 1, antenatal | | | | 75 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | SLC12A3 CL E G H | 6559 | 10912 | OMIM:263800 | Gitelman syndrome | | | | 145 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | SLC22A12 CL E G H | 116085 | 17989 | OMIM:220150 | Hypouricemia, renal, 1 | | | | 56 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | SLC25A20 CL E G H | 788 | 1421 | ORPHA:159 | Carnitine-acylcarnitine translocase deficiency | | | | 40 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | SLC34A1 CL E G H | 6569 | 11019 | OMIM:616963 | HYPERCALCEMIA, INFANTILE, 2; HCINF2 | | | | 47 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | SLC41A1 CL E G H | 254428 | 19429 | OMIM:619468 | NEPHRONOPHTHISIS-LIKE NEPHROPATHY 2; NPHPL2 | | | | | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | SLC5A2 CL E G H | 6524 | 11037 | OMIM:233100 | Renal glucosuria | | | | 41 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | SON CL E G H | 6651 | 11183 | OMIM:617140 | Zttk syndrome | | | | 12 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | THBD CL E G H | 7056 | 11784 | OMIM:612926 | Hemolytic uremic syndrome, atypical, susceptibility to, 6 | | | | 60 | | |
HP:0011036 | HP:0012590 | Abnormal urine output | 1 | TMEM67 CL E G H | 91147 | 28396 | OMIM:613550 | NEPHRONOPHTHISIS 11; NPHP11 | | | | 166 | | |
HP:0011036 | HP:0011037 | Decreased urine output | 2 | ACE CL E G H | 1636 | 2707 | OMIM:267430 | Renal tubular dysgenesis | | | | 113 | | |
HP:0011036 | HP:0011037 | Decreased urine output | 2 | AGT CL E G H | 183 | 333 | OMIM:267430 | Renal tubular dysgenesis | | | | 48 | | |
HP:0011036 | HP:0011037 | Decreased urine output | 2 | AGTR1 CL E G H | 185 | 336 | OMIM:267430 | Renal tubular dysgenesis | | | | 33 | | |
HP:0011036 | HP:0011037 | Decreased urine output | 2 | APRT CL E G H | 353 | 626 | ORPHA:976 | Adenine phosphoribosyltransferase deficiency | | | | 19 | | |
HP:0011036 | HP:0011037 | Decreased urine output | 2 | APRT CL E G H | 353 | 626 | OMIM:614723 | Adenine phosphoribosyltransferase deficiency | | | | 19 | | |
HP:0011036 | HP:0000103 | Polyuria | 2 | AQP2 CL E G H | 359 | 634 | OMIM:125800 | Diabetes insipidus, nephrogenic, 2 | | | | 75 | | |
HP:0011036 | HP:0000103 | Polyuria | 2 | ATP1A1 CL E G H | 476 | 799 | OMIM:618314 | Hypomagnesemia, seizures, and mental retardation 2 | . | | | 4 | | |
HP:0011036 | HP:0000103 | Polyuria | 2 | AVPR2 CL E G H | 554 | 897 | OMIM:304800 | Diabetes insipidus, nephrogenic, X-linked | . | | | 67 | | |
HP:0011036 | HP:0000103 | Polyuria | 2 | BSND CL E G H | 7809 | 16512 | OMIM:602522 | Bartter syndrome, type 4A, neonatal, with sensorineural deafness | . | | | 53 | | |
HP:0011036 | HP:0011037 | Decreased urine output | 2 | C3 CL E G H | 718 | 1318 | OMIM:612925 | Hemolytic uremic syndrome, atypical, susceptibility to, 5 | | | | 92 | | |
HP:0011036 | HP:0000103 | Polyuria | 2 | CASR CL E G H | 846 | 1514 | OMIM:239200 | Hyperparathyroidism, neonatal severe | . | | | 272 | | |
HP:0011036 | HP:0011037 | Decreased urine output | 2 | CAV1 CL E G H | 857 | 1527 | ORPHA:220393 | Diffuse cutaneous systemic sclerosis | | | | 11 | | |
HP:0011036 | HP:0000103 | Polyuria | 2 | CAV1 CL E G H | 857 | 1527 | OMIM:606721 | Lipodystrophy, familial partial, type 7 | | | | 11 | | |
HP:0011036 | HP:0011037 | Decreased urine output | 2 | CCN2 CL E G H | 1490 | 2500 | ORPHA:220393 | Diffuse cutaneous systemic sclerosis | | | | | | |
HP:0011036 | HP:0011037 | Decreased urine output | 2 | CCR6 CL E G H | 1235 | 1607 | ORPHA:220393 | Diffuse cutaneous systemic sclerosis | | | | | | |
HP:0011036 | HP:0011037 | Decreased urine output | 2 | CD46 CL E G H | 4179 | 6953 | OMIM:612922 | Hemolytic uremic syndrome, atypical, susceptibility to, 2 | | | | 39 | | |
HP:0011036 | HP:0011037 | Decreased urine output | 2 | CFB CL E G H | 629 | 1037 | OMIM:612924 | Hemolytic uremic syndrome, atypical, susceptibility to, 4 | | | | 30 | | |
HP:0011036 | HP:0011037 | Decreased urine output | 2 | CFH CL E G H | 3075 | 4883 | OMIM:235400 | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | | | | 86 | | |
HP:0011036 | HP:0011037 | Decreased urine output | 2 | CFHR1 CL E G H | 3078 | 4888 | OMIM:235400 | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | | | | | | |
HP:0011036 | HP:0011037 | Decreased urine output | 2 | CFHR3 CL E G H | 10878 | 16980 | OMIM:235400 | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | | | | | | |
HP:0011036 | HP:0011037 | Decreased urine output | 2 | CFI CL E G H | 3426 | 5394 | OMIM:612923 | Hemolytic uremic syndrome, atypical, susceptibility to, 3 | | | | 57 | | |
HP:0011036 | HP:0000103 | Polyuria | 2 | CLCNKA CL E G H | 1187 | 2026 | OMIM:613090 | Bartter syndrome, type 4B, neonatal, with sensorineural deafness | . | | | 9 | | |
HP:0011036 | HP:0000103 | Polyuria | 2 | CLCNKB CL E G H | 1188 | 2027 | OMIM:607364 | Bartter syndrome, type 3 | . | | | 27 | | |
HP:0011036 | HP:0000103 | Polyuria | 2 | CLCNKB CL E G H | 1188 | 2027 | OMIM:613090 | Bartter syndrome, type 4B, neonatal, with sensorineural deafness | . | | | 27 | | |
HP:0011036 | HP:0000103 | Polyuria | 2 | CLDN10 CL E G H | 9071 | 2033 | OMIM:617671 | Helix syndrome | . | | | 3 | | |
HP:0011036 | HP:0000103 | Polyuria | 2 | CLDN16 CL E G H | 10686 | 2037 | OMIM:248250 | Hypomagnesemia 3, renal | . | | | 58 | | |
HP:0011036 | HP:0011037 | Decreased urine output | 2 | COX1 CL E G H | 4512 | 7419 | ORPHA:99845 | Genetic recurrent myoglobinuria | | | | | | |
HP:0011036 | HP:0011037 | Decreased urine output | 2 | COX3 CL E G H | 4514 | 7422 | ORPHA:99845 | Genetic recurrent myoglobinuria | | | | | | |
HP:0011036 | HP:0000103 | Polyuria | 2 | CTNS CL E G H | 1497 | 2518 | OMIM:219800 | Cystinosis, nephropathic | . | | | 178 | | |
HP:0011036 | HP:0000103 | Polyuria | 2 | CYP24A1 CL E G H | 1591 | 2602 | OMIM:143880 | Hypercalcemia, infantile, 1 | . | | | 73 | | |
HP:0011036 | HP:0011037 | Decreased urine output | 2 | DZIP1L CL E G H | 199221 | 26551 | ORPHA:731 | Autosomal recessive polycystic kidney disease | | | | 4 | | |
HP:0011036 | HP:0000103 | Polyuria | 2 | FAM20A CL E G H | 54757 | 23015 | OMIM:204690 | Enamel-Renal syndrome | . | | | 16 | | |
HP:0011036 | HP:0011037 | Decreased urine output | 2 | HLA-DRB1 CL E G H | 3123 | 4948 | ORPHA:220393 | Diffuse cutaneous systemic sclerosis | | | | 2 | | |
HP:0011036 | HP:0000103 | Polyuria | 2 | HNF1A CL E G H | 6927 | 11621 | OMIM:222100 | Diabetes mellitus, insulin-dependent-1 | . | | | 161 | | |
HP:0011036 | HP:0000103 | Polyuria | 2 | IL6 CL E G H | 3569 | 6018 | OMIM:222100 | Diabetes mellitus, insulin-dependent-1 | . | | | 2 | | |
HP:0011036 | HP:0011037 | Decreased urine output | 2 | IRF5 CL E G H | 3663 | 6120 | ORPHA:220393 | Diffuse cutaneous systemic sclerosis | | | | 4 | | |
HP:0011036 | HP:0000103 | Polyuria | 2 | ITPR3 CL E G H | 3710 | 6182 | OMIM:222100 | Diabetes mellitus, insulin-dependent-1 | . | | | | | |
HP:0011036 | HP:0000103 | Polyuria | 2 | KCNJ1 CL E G H | 3758 | 6255 | OMIM:241200 | Bartter syndrome, antenatal, type 2 | . | | | 51 | | |
HP:0011036 | HP:0000103 | Polyuria | 2 | KCNJ10 CL E G H | 3766 | 6256 | OMIM:612780 | Seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance | . | | | 121 | | |
HP:0011036 | HP:0000103 | Polyuria | 2 | KCNJ5 CL E G H | 3762 | 6266 | OMIM:613677 | Hyperaldosteronism, familial, type III | HP:0040283 - Occasional | | | 128 | | |
HP:0011036 | HP:0011037 | Decreased urine output | 2 | LPIN1 CL E G H | 23175 | 13345 | ORPHA:99845 | Genetic recurrent myoglobinuria | | | | 95 | | |
HP:0011036 | HP:0000103 | Polyuria | 2 | LZTFL1 CL E G H | 54585 | 6741 | OMIM:615994 | BARDET-BIEDL SYNDROME 17; BBS17 | | | | 4 | | |
HP:0011036 | HP:0000103 | Polyuria | 2 | MAGED2 CL E G H | 10916 | 16353 | OMIM:300971 | Bartter syndrome, type 5, antenatal, transient | | | | 6 | | |
HP:0011036 | HP:0011037 | Decreased urine output | 2 | MYH11 CL E G H | 4629 | 7569 | OMIM:619351 | MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME 2; MMIHS2 | | | | 418 | | |
HP:0011036 | HP:0000103 | Polyuria | 2 | NPHP1 CL E G H | 4867 | 7905 | OMIM:256100 | Nephronophthisis 1 | . | | | 85 | | |
HP:0011036 | HP:0000103 | Polyuria | 2 | NPHP1 CL E G H | 4867 | 7905 | OMIM:266900 | Senior-Loken syndrome 1 | . | | | 85 | | |
HP:0011036 | HP:0000103 | Polyuria | 2 | NPHP3 CL E G H | 27031 | 7907 | OMIM:604387 | Nephronophthisis 3 | . | | | 157 | | |
HP:0011036 | HP:0000103 | Polyuria | 2 | NPHP4 CL E G H | 261734 | 19104 | OMIM:606966 | Nephronophthisis 4 | . | | | 220 | | |
HP:0011036 | HP:0000103 | Polyuria | 2 | NPHP4 CL E G H | 261734 | 19104 | OMIM:606996 | Senior-Loken syndrome 4 | . | | | 220 | | |
HP:0011036 | HP:0011037 | Decreased urine output | 2 | PAX2 CL E G H | 5076 | 8616 | ORPHA:97362 | Renal hypoplasia, bilateral | | | | 39 | | |
HP:0011036 | HP:0011037 | Decreased urine output | 2 | PBX1 CL E G H | 5087 | 8632 | ORPHA:97362 | Renal hypoplasia, bilateral | | | | 3 | | |
HP:0011036 | HP:0011037 | Decreased urine output | 2 | PKHD1 CL E G H | 5314 | 9016 | ORPHA:731 | Autosomal recessive polycystic kidney disease | | | | 563 | | |
HP:0011036 | HP:0000103 | Polyuria | 2 | PLVAP CL E G H | 83483 | 13635 | OMIM:618183 | Diarrhea 10, protein-losing Enteropathy type | . | | | | | |
HP:0011036 | HP:0000103 | Polyuria | 2 | PTPN22 CL E G H | 26191 | 9652 | OMIM:222100 | Diabetes mellitus, insulin-dependent-1 | . | | | 3 | | |
HP:0011036 | HP:0011037 | Decreased urine output | 2 | REN CL E G H | 5972 | 9958 | OMIM:267430 | Renal tubular dysgenesis | | | | 25 | | |
HP:0011036 | HP:0011037 | Decreased urine output | 2 | RYR1 CL E G H | 6261 | 10483 | ORPHA:466650 | Exercise-induced malignant hyperthermia | | | | 1200 | | |
HP:0011036 | HP:0000103 | Polyuria | 2 | SARS2 CL E G H | 54938 | 17697 | OMIM:613845 | Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis syndrome | . | | | 60 | | |
HP:0011036 | HP:0000103 | Polyuria | 2 | SLC12A1 CL E G H | 6557 | 10910 | OMIM:601678 | Bartter syndrome, type 1, antenatal | . | | | 75 | | |
HP:0011036 | HP:0000103 | Polyuria | 2 | SLC12A3 CL E G H | 6559 | 10912 | OMIM:263800 | Gitelman syndrome | | | | 145 | | |
HP:0011036 | HP:0011037 | Decreased urine output | 2 | SLC22A12 CL E G H | 116085 | 17989 | OMIM:220150 | Hypouricemia, renal, 1 | | | | 56 | | |
HP:0011036 | HP:0011037 | Decreased urine output | 2 | SLC25A20 CL E G H | 788 | 1421 | ORPHA:159 | Carnitine-acylcarnitine translocase deficiency | | | | 40 | | |
HP:0011036 | HP:0000103 | Polyuria | 2 | SLC34A1 CL E G H | 6569 | 11019 | OMIM:616963 | HYPERCALCEMIA, INFANTILE, 2; HCINF2 | | | | 47 | | |
HP:0011036 | HP:0000103 | Polyuria | 2 | SLC41A1 CL E G H | 254428 | 19429 | OMIM:619468 | NEPHRONOPHTHISIS-LIKE NEPHROPATHY 2; NPHPL2 | | | | | | |
HP:0011036 | HP:0000103 | Polyuria | 2 | SLC5A2 CL E G H | 6524 | 11037 | OMIM:233100 | Renal glucosuria | . | | | 41 | | |
HP:0011036 | HP:0000103 | Polyuria | 2 | SON CL E G H | 6651 | 11183 | OMIM:617140 | Zttk syndrome | | | | 12 | | |
HP:0011036 | HP:0011037 | Decreased urine output | 2 | THBD CL E G H | 7056 | 11784 | OMIM:612926 | Hemolytic uremic syndrome, atypical, susceptibility to, 6 | | | | 60 | | |
HP:0011036 | HP:0000103 | Polyuria | 2 | TMEM67 CL E G H | 91147 | 28396 | OMIM:613550 | NEPHRONOPHTHISIS 11; NPHP11 | | | | 166 | | |
HP:0011036 | HP:0100519 | Anuria | 3 | ACE CL E G H | 1636 | 2707 | OMIM:267430 | Renal tubular dysgenesis | . | | | 113 | | |
HP:0011036 | HP:0100519 | Anuria | 3 | AGT CL E G H | 183 | 333 | OMIM:267430 | Renal tubular dysgenesis | . | | | 48 | | |
HP:0011036 | HP:0100519 | Anuria | 3 | AGTR1 CL E G H | 185 | 336 | OMIM:267430 | Renal tubular dysgenesis | . | | | 33 | | |
HP:0011036 | HP:0100520 | Oliguria | 3 | APRT CL E G H | 353 | 626 | OMIM:614723 | Adenine phosphoribosyltransferase deficiency | | | | 19 | | |
HP:0011036 | HP:0100520 | Oliguria | 3 | APRT CL E G H | 353 | 626 | ORPHA:976 | Adenine phosphoribosyltransferase deficiency | HP:0040283 - Occasional | | | 19 | | |
HP:0011036 | HP:0100519 | Anuria | 3 | C3 CL E G H | 718 | 1318 | OMIM:612925 | Hemolytic uremic syndrome, atypical, susceptibility to, 5 | . | | | 92 | | |
HP:0011036 | HP:0100520 | Oliguria | 3 | CAV1 CL E G H | 857 | 1527 | ORPHA:220393 | Diffuse cutaneous systemic sclerosis | HP:0040281 - Very frequent | | | 11 | | |
HP:0011036 | HP:0100520 | Oliguria | 3 | CCN2 CL E G H | 1490 | 2500 | ORPHA:220393 | Diffuse cutaneous systemic sclerosis | HP:0040281 - Very frequent | | | | | |
HP:0011036 | HP:0100520 | Oliguria | 3 | CCR6 CL E G H | 1235 | 1607 | ORPHA:220393 | Diffuse cutaneous systemic sclerosis | HP:0040281 - Very frequent | | | | | |
HP:0011036 | HP:0100519 | Anuria | 3 | CD46 CL E G H | 4179 | 6953 | OMIM:612922 | Hemolytic uremic syndrome, atypical, susceptibility to, 2 | . | | | 39 | | |
HP:0011036 | HP:0100519 | Anuria | 3 | CFB CL E G H | 629 | 1037 | OMIM:612924 | Hemolytic uremic syndrome, atypical, susceptibility to, 4 | . | | | 30 | | |
HP:0011036 | HP:0100519 | Anuria | 3 | CFH CL E G H | 3075 | 4883 | OMIM:235400 | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | . | | | 86 | | |
HP:0011036 | HP:0100519 | Anuria | 3 | CFHR1 CL E G H | 3078 | 4888 | OMIM:235400 | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | . | | | | | |
HP:0011036 | HP:0100519 | Anuria | 3 | CFHR3 CL E G H | 10878 | 16980 | OMIM:235400 | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | . | | | | | |
HP:0011036 | HP:0100519 | Anuria | 3 | CFI CL E G H | 3426 | 5394 | OMIM:612923 | Hemolytic uremic syndrome, atypical, susceptibility to, 3 | . | | | 57 | | |
HP:0011036 | HP:0100520 | Oliguria | 3 | COX1 CL E G H | 4512 | 7419 | ORPHA:99845 | Genetic recurrent myoglobinuria | | | | | | |
HP:0011036 | HP:0100520 | Oliguria | 3 | COX3 CL E G H | 4514 | 7422 | ORPHA:99845 | Genetic recurrent myoglobinuria | | | | | | |
HP:0011036 | HP:0100520 | Oliguria | 3 | DZIP1L CL E G H | 199221 | 26551 | ORPHA:731 | Autosomal recessive polycystic kidney disease | HP:0040283 - Occasional | | | 4 | | |
HP:0011036 | HP:0100520 | Oliguria | 3 | HLA-DRB1 CL E G H | 3123 | 4948 | ORPHA:220393 | Diffuse cutaneous systemic sclerosis | HP:0040281 - Very frequent | | | 2 | | |
HP:0011036 | HP:0100520 | Oliguria | 3 | IRF5 CL E G H | 3663 | 6120 | ORPHA:220393 | Diffuse cutaneous systemic sclerosis | HP:0040281 - Very frequent | | | 4 | | |
HP:0011036 | HP:0100520 | Oliguria | 3 | LPIN1 CL E G H | 23175 | 13345 | ORPHA:99845 | Genetic recurrent myoglobinuria | | | | 95 | | |
HP:0011036 | HP:0100519 | Anuria | 3 | MYH11 CL E G H | 4629 | 7569 | OMIM:619351 | MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME 2; MMIHS2 | | | | 418 | | |
HP:0011036 | HP:0100520 | Oliguria | 3 | PAX2 CL E G H | 5076 | 8616 | ORPHA:97362 | Renal hypoplasia, bilateral | | | | 39 | | |
HP:0011036 | HP:0100520 | Oliguria | 3 | PBX1 CL E G H | 5087 | 8632 | ORPHA:97362 | Renal hypoplasia, bilateral | | | | 3 | | |
HP:0011036 | HP:0100520 | Oliguria | 3 | PKHD1 CL E G H | 5314 | 9016 | ORPHA:731 | Autosomal recessive polycystic kidney disease | HP:0040283 - Occasional | | | 563 | | |
HP:0011036 | HP:0100519 | Anuria | 3 | REN CL E G H | 5972 | 9958 | OMIM:267430 | Renal tubular dysgenesis | . | | | 25 | | |
HP:0011036 | HP:0100520 | Oliguria | 3 | RYR1 CL E G H | 6261 | 10483 | ORPHA:466650 | Exercise-induced malignant hyperthermia | HP:0040283 - Occasional | | | 1200 | | |
HP:0011036 | HP:0100520 | Oliguria | 3 | SLC22A12 CL E G H | 116085 | 17989 | OMIM:220150 | Hypouricemia, renal, 1 | | | | 56 | | |
HP:0011036 | HP:0100520 | Oliguria | 3 | SLC25A20 CL E G H | 788 | 1421 | ORPHA:159 | Carnitine-acylcarnitine translocase deficiency | HP:0040283 - Occasional | | | 40 | | |
HP:0011036 | HP:0100519 | Anuria | 3 | THBD CL E G H | 7056 | 11784 | OMIM:612926 | Hemolytic uremic syndrome, atypical, susceptibility to, 6 | . | | | 60 | | |